Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product & Service Segment
1.2.2. Grade Segment
1.2.3. Application Segment
1.2.4. End Use Segment
1.3. Information Analysis
1.3.1. Market formulation & data visualization
1.4. Data Validation & Publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. U.S. Plasmid Purification Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Vaccine development (especially DNA vaccines)
3.2.1.2. Rise in biopharmaceutical R&D
3.2.2. Market restraint analysis
3.2.2.1. Ethical constraints related to the use of rDNA technology
3.3. U.S. Plasmid Purification Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. U.S. Plasmid Purification Market: Product & Service Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Plasmid Purification Market Product & Service Movement Analysis
4.3. U.S. Plasmid Purification Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
4.4. Products
4.4.1. Products market estimates and forecasts, 2021-2033 (USD Million)
4.4.2. Instruments
4.4.2.1. Instruments market estimates and forecasts, 2021-2033 (USD Million)
4.4.3. Kits & Reagents
4.4.3.1. Kits & reagents market estimates and forecasts, 2021-2033 (USD Million)
4.5. Services
4.5.1. Services market estimates and forecasts, 2021-2033 (USD Million)
Chapter 5. U.S. Plasmid Purification Market: Grade Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. Plasmid Purification Market Grade Movement Analysis
5.3. U.S. Plasmid Purification Market Size & Trend Analysis, by Grade, 2021 to 2033 (USD Million)
5.4. Molecular Grade
5.4.1. Molecular-grade market estimates and forecasts, 2021-2033 (USD Million)
5.5. Transfection Grade
5.5.1. Transfection grade market estimates and forecasts, 2021-2033 (USD Million)
Chapter 6. U.S. Plasmid Purification Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. U.S. Plasmid Purification Market Application Movement Analysis
6.3. U.S. Plasmid Purification Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Cloning & Protein Expression
6.4.1. Cloning & protein expression market estimates and forecasts, 2021-2033 (USD Million)
6.5. Transfection & Gene Editing
6.5.1. Transfection & gene editing market estimates and forecasts, 2021-2033 (USD Million)
6.6. Others
6.6.1. Others market estimates and forecasts, 2021-2033 (USD Million)
Chapter 7. U.S. Plasmid Purification Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. U.S. Plasmid Purification Market End Use Movement Analysis
7.3. U.S. Plasmid Purification Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.4. Pharmaceutical & Biotechnology Companies
7.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2021-2033 (USD Million)
7.5. Academic & Research Institutes
7.5.1. Academic & research institutes market estimates and forecasts, 2021-2033 (USD Million)
7.6. Contract Research Organizations
7.6.1. Contract research organizations market estimates and forecasts, 2021-2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2024
8.4. Company Profiles/Listing
8.4.1. Merck KGaA
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product/Service benchmarking
8.4.1.4. Strategic initiatives
8.4.2. QIAGEN
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product/Service benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Thermo Fisher Scientific, Inc.
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product/Service benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Takara Bio
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product/Service benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Promega Corporation
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product/Service benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Zymo Research
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product/Service benchmarking
8.4.6.4. Strategic initiatives
8.4.7. MP BIOMEDICALS
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product/Service benchmarking
8.4.7.4. Strategic initiatives
8.4.8. New England Biolabs
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product/Service benchmarking
8.4.8.4. Strategic initiatives
8.4.9. MCLAB
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product/Service benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Applied Biological Materials, Inc.
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product/Service benchmarking
8.4.10.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 U.S. plasmid purification market, by product & service, 2021-2033 (USD Million)
Table 3 U.S. plasmid purification market, by grade, 2021-2033 (USD Million)
Table 4 U.S. plasmid purification market, by application, 2021-2033 (USD Million)
Table 5 U.S. plasmid purification market, by end use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Market formulation & validation
Figure 4 U.S. Plasmid purification market: Market outlook
Figure 5 U.S. Plasmid purification market: Segment outlook
Figure 6 U.S. Plasmid purification market: Competitive landscape outlook
Figure 7 Parent market outlook
Figure 8 U.S. Plasmid purification market driver impact
Figure 9 U.S. Plasmid purification market restraint impact
Figure 10 U.S. Plasmid purification market: Product & service outlook and key takeaways
Figure 11 U.S. Plasmid purification market: Product & service movement analysis
Figure 12 Products market estimates and forecast, 2021-2033 (USD Million)
Figure 13 Instruments market estimates and forecast, 2021-2033 (USD Million)
Figure 14 Kits & reagents market estimates and forecast, 2021-2033 (USD Million)
Figure 15 Services market estimates and forecast, 2021-2033 (USD Million)
Figure 16 U.S. Plasmid purification market: Grade outlook and key takeaways
Figure 17 U.S. Plasmid purification market: Grade movement analysis
Figure 18 Molecular-grade market estimates and forecast, 2021-2033 (USD Million)
Figure 19 Transfection grade market estimates and forecast, 2021-2033 (USD Million)
Figure 20 U.S. Plasmid purification market: Application outlook and key takeaways
Figure 21 U.S. Plasmid purification market: Application movement analysis
Figure 22 Cloning & protein expression market estimates and forecast, 2021-2033 (USD Million)
Figure 23 Transfection & gene editing market estimates and forecast, 2021-2033 (USD Million)
Figure 24 Others market estimates and forecast, 2021-2033 (USD Million)
Figure 25 U.S. Plasmid purification market: End use outlook and key takeaways
Figure 26 U.S. Plasmid purification market: End use movement analysis
Figure 27 Pharmaceutical & biotechnology companies market estimates and forecasts,2021-2033 (USD Million)
Figure 28 Academic & research institutes market estimates and forecasts, 2021-2033 (USD Million)
Figure 29 Contract research organizations market estimates and forecasts, 2021-2033 (USD Million)
